BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Novartis Oncology Head to Retire for Personal Reasons

  Bruno Strigini, the CEO of Novartis Oncology, plans to exit the company’s Executive Committee by Dec. 31, 2017, and leave entirely in early 2018.

  December 15, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Biotechs Drool as VC Firm Andreessen Horowitz Doubles Down on the Life Sciences With New $450M Fund

  Biotechs are taking notice as a new pool of funding is being made available by venture capital Andreesen Horowitz.

  December 15, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Suitors Line Up for Merck KGaA’s $4.7B Consumer Health Biz

  Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada.

  December 15, 2017

   · 

  1 min read
• 

  Business

  Boehringer CFO Quits After 16 Months on the Job Over Differences in Strategy

  Boehringer’s global head of information technology, Michael Schmelmer, will replace Menne on Jan. 1, 2018.

  December 15, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  How Amicus CEO Personally Appealed to FDA Head to Get Migalastat Back on Track

  Industry analysts were shocked when in July the FDA reversed course on Amicus’ Phase III treatment for Fabry disease.

  December 15, 2017

   · 

  4 min read

   · 

  Alex Keown
• Clover Bio of Chengdu Completes $9.5M Series A for Biotech/Biosimilar Portfolio

  Clover Biopharmaceuticals, a Chengdu biotech startup, completed a $9.5M Series A financing led by Tianhe Life Sciences Venture Fund.

  December 15, 2017

   · 

  1 min read
• 

  Biotech Bay

  Why AbbVie’s Booming 2017 Could Continue in 2018

  Now that 2017 is drawing to an end, though, it’s time to focus on the new year.

  December 15, 2017

   · 

  1 min read
• 

  BioMidwest

  3 Medtech Stocks to Load Up On in an Iffy Medtech Market

  A look at three of the best performing medtech stocks out there right now.

  December 15, 2017

   · 

  1 min read
• Drug Development

  Swedish Cell Therapy Candidate CellProtect has Received Orphan Drug Designation for the Treatment of Multiple Myeloma

  The work on a clinical trial report to the Swedish Medical Products Agency is on-going and the plan is to publish the results in 2018.

  December 15, 2017

   · 

  3 min read
• 

  Drug Development

  Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam’s Fitusiran

  Clinical trial dosing will resume around year-end 2017.

  December 15, 2017

   · 

  8 min read